Clinical Trial Update: Remimazolam for Emergence Delirium Prevention in Patients Undergoing Rhinoseptoplasty, FESS or Septoplasty [Phase 2]

View source ↗

Summary

This document describes a Phase 2 clinical trial evaluating remimazolam to prevent emergence delirium in patients undergoing rhinoseptoplasty, functional endosc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Emergence Delirium

Drugs mentioned

• Remimazolam (remimazolam)

Snippet

Sponsor: University Hospital of Split | Conditions: Remimazolam, Emergence Delirium | Phase 2 | Status: UNKNOWN